Iron protein succinate oral solution
By using specific combination components and pH adjustment in the oral solution of protein iron succinate, the problem of poor solution stability is solved, excellent photothermal stability and safety is achieved, and transportation and storage costs are reduced.
Patent Information
- Application Number
- CN202411188468.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-11-26
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing oral solution of protein iron succinate has poor stability and is prone to precipitation and increased impurity content during storage and transportation, resulting in difficulty in ensuring quality and safety, which increases storage and transportation costs.
Using the combination of protein succinate, glycerin, polyethylene glycol 400, fructose, xylitol, trehalose, glycine and water, the pH value is adjusted by specific ratios and sodium hydroxide to prepare protein amber with excellent stability. Iron Acid Oral Solution.
It improves the photothermal stability of the oral solution of protein iron succinate, reduces storage and transportation costs, and ensures quality and safety of medication.
Smart Images

Figure BDA0005016922440000011 
Figure BDA0005016922440000021 
Figure BDA0005016922440000022
Abstract
Description
Technical Field
[0001] The invention relates to the field of pharmaceutical preparations, and in particular to an oral iron protein succinate solution. Background Art
[0002] Iron protein succinate (CAS registration number: 93615-44-2) is suitable for absolute and relative iron deficiency anemia, latent or dominant iron deficiency anemia caused by insufficient iron intake or malabsorption, acute or chronic blood loss and infection, and anemia during pregnancy and lactation.
[0003] Iron protein succinate oral solution is widely used clinically because of its advantages such as convenient administration and rapid onset of action, and is particularly suitable for children, the elderly or patients with dysphagia, thereby improving patient compliance. However, the existing iron protein succinate oral solution is easily affected by various factors such as heat, resulting in poor stability of the iron protein succinate oral solution. Poor stability easily leads to precipitation and increased impurity content of the iron protein succinate oral solution during storage and transportation, making it difficult to ensure the quality and safety of the iron protein succinate oral solution, and thus it is difficult to effectively ensure the safety of medication. Therefore, higher storage and transportation requirements are often required, which increases storage and transportation costs. How to improve the stability of the iron protein succinate oral solution is very important for ensuring the quality of the iron protein succinate oral solution, and has become a research hotspot in the field of pharmaceutical preparations.
[0004] Therefore, there is a need in the art to develop an iron protein succinate oral solution with excellent stability. Summary of the invention
[0005] The object of the present invention is to provide an oral iron protein succinate solution with excellent stability.
[0006] In a first aspect, the present invention provides an oral solution of iron protein succinate, which comprises iron protein succinate, glycerol, polyethylene glycol 400, fructose, xylitol, trehalose, glycine and water.
[0007] Preferably, the iron protein succinate is 6-10 parts by weight, more preferably 7-9 parts by weight, more preferably 7.5-8.5 parts by weight, most preferably 7.8-8.2 parts by weight, and most preferably 8.0 parts by weight.
[0008] Preferably, the glycerol is 1-3 parts by weight, more preferably 1.5-2.5 parts by weight, more preferably 1.8-2.2 parts by weight, and most preferably 2.0 parts by weight.
[0009] Preferably, the polyethylene glycol 400 is 3-5 parts by weight, more preferably 3.5-4.5 parts by weight, more preferably 3.8-4.2 parts by weight, and most preferably 4.0 parts by weight.
[0010] Preferably, the fructose is 5-7 parts by weight, more preferably 5.5-6.5 parts by weight, more preferably 5.8-6.2 parts by weight, and most preferably 6.0 parts by weight.
[0011] Preferably, the xylitol is 0.5-2.0 parts by weight, more preferably 0.8-1.5 parts by weight, more preferably 1.0-1.4 parts by weight, and most preferably 1.2 parts by weight.
[0012] Preferably, the trehalose is 1-4 parts by weight, more preferably 2-3 parts by weight, more preferably 2.3-2.7 parts by weight, and most preferably 2.5 parts by weight.
[0013] Preferably, the glycine is 2-4 parts by weight, more preferably 2.5-3.5 parts by weight, more preferably 2.8-3.2 parts by weight, and most preferably 3.0 parts by weight.
[0014] Preferably, the water is 130-170 parts by weight, more preferably 140-160 parts by weight, more preferably 145-155 parts by weight, and most preferably 150 parts by weight.
[0015] Preferably, the water is purified water.
[0016] Preferably, the iron protein succinate oral solution comprises:
[0017]
[0018]
[0019] Preferably, the iron protein succinate oral solution comprises:
[0020] Components Dosage Iron Proteinate 7.5-8.5 parts by weight glycerin 1.5-2.5 parts by weight Polyethylene glycol 400 3.5-4.5 parts by weight fructose 5.5-6.5 parts by weight Xylitol 0.8-1.5 parts by weight Trehalose 2-3 parts by weight Glycine 2.5-3.5 parts by weight; and water 140-160 parts by weight.
[0021] Preferably, the iron protein succinate oral solution comprises:
[0022] Components Dosage Iron Proteinate 7.8-8.2 parts by weight glycerin 1.8-2.2 parts by weight Polyethylene glycol 400 3.8-4.2 parts by weight fructose 5.8-6.2 parts by weight Xylitol 1.0-1.4 parts by weight Trehalose 2.3-2.7 parts by weight Glycine 2.8-3.2 parts by weight; and water 145-155 parts by weight.
[0023] Preferably, the iron protein succinate oral solution comprises:
[0024] Components Dosage Iron Proteinate 8.0 parts by weight glycerin 2.0 parts by weight Polyethylene glycol 400 4.0 parts by weight fructose 6.0 parts by weight Xylitol 1.2 parts by weight Trehalose 2.5 parts by weight Glycine 3.0 parts by weight; and water 150 parts by weight.
[0025] Preferably, the iron protein succinate oral solution comprises:
[0026]
[0027]
[0028] Preferably, the pH of the oral solution of iron protein succinate is 6.0-8.5, preferably 7.0-8.2, more preferably 7.2-8.0, more preferably 7.4-7.8, and most preferably 7.6.
[0029] Preferably, the oral solution of iron protein succinate further comprises sodium hydroxide.
[0030] Preferably, the pH of the ferric proteinase succinate oral solution is adjusted with sodium hydroxide.
[0031] Preferably, the pH of the oral solution of ferric protein succinate is adjusted to 6.0-8.5 with sodium hydroxide, preferably 7.0-8.2, more preferably 7.2-8.0, more preferably 7.4-7.8, and most preferably 7.6.
[0032] The second aspect of the present invention provides a method for preparing the oral solution of iron protein succinate as described in the first aspect of the present invention, wherein the method comprises the steps of:
[0033] The iron protein succinate oral solution is obtained by mixing iron protein succinate, glycerol, polyethylene glycol 400, fructose, xylitol, trehalose, glycine and water.
[0034] Preferably, the method further comprises adjusting the pH of the ferric protein succinate oral solution with sodium hydroxide.
[0035] Preferably, the method further comprises adjusting the pH of the oral ferric protein succinate solution to 6.0-8.5, preferably 7.0-8.2, more preferably 7.2-8.0, more preferably 7.4-7.8, and most preferably 7.6, using sodium hydroxide.
[0036] Preferably, the iron protein succinate oral solution is prepared by the following method:
[0037] Take 75-85% of the prescribed amount of water after boiling and cooling, add glycerol and polyethylene glycol 400, stir, add iron protein succinate, fructose, xylitol, trehalose and glycine, stir, adjust the pH with sodium hydroxide, stir, add boiled and cooled water to make up to the dosage volume, filter through a filter membrane to obtain an oral solution of iron protein succinate.
[0038] Preferably, the stirring comprises stirring at 45-55°C (such as 50°C).
[0039] Preferably, the iron protein succinate oral solution is prepared by the following method:
[0040] Take 80% of the prescribed amount of water that has been boiled and cooled, add glycerol and polyethylene glycol 400, stir at 50°C, add iron protein succinate, fructose, xylitol, trehalose and glycine, stir at 50°C, adjust the pH to 7.6 with sodium hydroxide, stir, add boiled and cooled purified water to make up to the dosage volume, filter through a filter membrane to obtain an oral solution of iron protein succinate.
[0041] The third aspect of the present invention provides a medicine kit, wherein the medicine kit comprises the oral iron protein succinate solution as described in the first aspect of the present invention.
[0042] Preferably, the medicine kit further comprises a container, and the oral solution of ferric protein succinate is dispensed in the container.
[0043] Preferably, the transparent container comprises a white plastic bottle.
[0044] In a fourth aspect, the present invention provides a use of the ferric protein succinate oral solution as described in the first aspect of the present invention for preparing a medicament for preventing and / or treating anemia.
[0045] Preferably, the anemia comprises iron deficiency anemia.
[0046] Preferably, the anemia includes absolute and relative iron deficiency anemia, latent or dominant iron deficiency anemia due to insufficient iron intake or malabsorption, acute or chronic blood loss or infection, or anemia during pregnancy and lactation.
[0047] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described below (such as embodiments) can be combined with each other to form new or preferred technical solutions. DETAILED DESCRIPTION
[0048] The present invention develops an oral iron protein succinate solution, which comprises iron protein succinate, glycerol, polyethylene glycol 400, fructose, xylitol, trehalose, glycine and water. The oral iron protein succinate solution composed of specific components of the present invention has excellent light and heat stability, can reduce storage and transportation costs, ensure the stability of the oral iron protein succinate solution during transportation and storage, and ensure quality safety and drug safety.
[0049] the term
[0050] As used herein, the terms "comprise", "include", and "contain" are used interchangeably and include not only closed definitions, but also semi-closed and open definitions. In other words, the terms include "consisting of", "consisting essentially of".
[0051] As used herein, the term "parts by weight" may be any fixed weight expressed in milligrams, grams or kilograms (such as 1 mg, 1 g or 1 kg, etc.). For example, a composition consisting of 1 part by weight of component a and 9 parts by weight of component b may be a composition consisting of 1 gram of component a + 9 grams of component b, or 10 grams of component a + 90 grams of component b, etc. In the pharmaceutical composition, the percentage content of a component = (parts by weight of the component / sum of the parts by weight of all components) × 100%. Therefore, in a composition consisting of 1 part by weight of component a and 9 parts by weight of component b, the content of component a is 10%, and the content of component b is 90%.
[0052] Iron protein succinate oral solution and preparation method thereof
[0053] The invention provides an oral iron protein succinate solution with excellent stability, thereby improving the application value of the oral iron protein succinate solution.
[0054] The ferric protein succinate oral solution of the present invention may include (but not limited to) ferric protein succinate, glycerol, polyethylene glycol 400, fructose, xylitol, trehalose, glycine and water.
[0055] In the oral iron protein succinate solution of the present invention, the components work together to make the oral iron protein succinate solution have excellent stability, thereby ensuring the stability of the oral iron protein succinate solution during transportation and storage, and ensuring quality safety and medication safety.
[0056] Typically, the iron protein succinate oral solution comprises:
[0057]
[0058] The pH of the ferric protein succinate oral solution was adjusted to 7.6 with sodium hydroxide.
[0059] Typically, the iron protein succinate oral solution comprises:
[0060]
[0061]
[0062] The pH of the ferric protein succinate oral solution was adjusted to 7.6 with sodium hydroxide.
[0063] Specifically, the oral solution of iron protein succinate described in the present invention is as described above in the first aspect of the present invention.
[0064] The iron protein succinate oral solution of the present invention can be prepared by a mixing method, for example, iron protein succinate, glycerol, polyethylene glycol 400, fructose, xylitol, trehalose, glycine and water are mixed to obtain the iron protein succinate oral solution.
[0065] Specifically, the preparation method of the iron protein succinate oral solution of the present invention is as described above in the second aspect of the present invention.
[0066] use
[0067] The present invention provides an application of the ferric protein succinate oral solution of the present invention for preparing a medicine for preventing and / or treating anemia.
[0068] In a preferred embodiment of the present invention, the anemia includes iron deficiency anemia, for example, the anemia includes absolute and relative iron deficiency anemia, latent or dominant iron deficiency anemia caused by insufficient iron intake or malabsorption, acute or chronic blood loss or infection, or anemia during pregnancy and lactation.
[0069] The main excellent technical effects of the present invention include:
[0070] The invention develops an oral iron protein succinate solution. The oral iron protein succinate solution has excellent light and heat stability, can reduce storage and transportation costs, ensures the stability of the oral iron protein succinate solution during transportation and storage, and ensures quality safety and medication safety.
[0071] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples where specific conditions are not specified are usually based on conventional conditions.
[0072] Example 1 Iron protein succinate oral solution
[0073] The prescription composition of the iron protein succinate oral solution of this embodiment 1 is shown in Table 1:
[0074] Table 1 Prescription composition of iron protein succinate oral solution
[0075] Components Dosage Iron Proteinate 8.0g glycerin 2.0g Polyethylene glycol 400 4.0g fructose 6.0g Xylitol 1.2g Trehalose 2.5g Glycine 3.0g Sodium hydroxide Moderate Add purified water Up to 150ml.
[0076] Preparation method:
[0077] Take 80% of the prescribed amount of purified water after boiling and cooling, add the prescribed amount of glycerol and the prescribed amount of polyethylene glycol 400, stir at 50°C, add the prescribed amount of protein succinate iron, the prescribed amount of fructose, the prescribed amount of xylitol, the prescribed amount of trehalose and the prescribed amount of glycine, stir at 50°C, adjust the pH to 7.6 with 4 mol / L sodium hydroxide aqueous solution, stir, add boiled and cooled purified water to make up to the dispensing volume, filter through a filter membrane to obtain the protein succinate iron oral solution.
[0078] Example 2 Iron protein succinate oral solution
[0079] The prescription composition of the iron protein succinate oral solution of this embodiment 2 is shown in Table 2:
[0080] Table 2 Prescription composition of iron protein succinate oral solution
[0081] Components Dosage Iron Proteinate 8.0g glycerin 2.0g Polyethylene glycol 400 2.0g fructose 6.0g Xylitol 1.2g Trehalose 2.5g Glycine 1.5g Sodium hydroxide Moderate Add purified water Up to 150ml.
[0082] Preparation method:
[0083] Take 80% of the prescribed amount of purified water after boiling and cooling, add the prescribed amount of glycerol and the prescribed amount of polyethylene glycol 400, stir at 50°C, add the prescribed amount of protein succinate iron, the prescribed amount of fructose, the prescribed amount of xylitol, the prescribed amount of trehalose and the prescribed amount of glycine, stir at 50°C, adjust the pH to 7.6 with 4 mol / L sodium hydroxide aqueous solution, stir, add boiled and cooled purified water to make up to the dispensing volume, filter through a filter membrane to obtain the protein succinate iron oral solution.
[0084] Example 3 Iron protein succinate oral solution
[0085] The prescription composition of the iron protein succinate oral solution of this embodiment 3 is shown in Table 3:
[0086] Table 3 Prescription composition of iron protein succinate oral solution
[0087] Components Dosage Iron Proteinate 8.0g Propylene glycol 2.0g Polyethylene glycol 400 4.0g fructose 6.0g Xylitol 1.2g Trehalose 2.5g Glycine 2.0g Sodium hydroxide Moderate Add purified water Up to 150ml.
[0088] Preparation method:
[0089] Take 80% of the prescribed amount of purified water after boiling and cooling, add the prescribed amount of propylene glycol and the prescribed amount of polyethylene glycol 400, stir at 50°C, add the prescribed amount of ferric protein succinate, the prescribed amount of fructose, the prescribed amount of xylitol, the prescribed amount of trehalose and the prescribed amount of glycine, stir at 50°C, adjust the pH to 7.6 with 4 mol / L sodium hydroxide aqueous solution, stir, add boiled and cooled purified water to make up to the dispensing volume, filter through a filter membrane to obtain an oral solution of ferric protein succinate.
[0090] Example 4 Iron protein succinate oral solution
[0091] The prescription composition of the iron protein succinate oral solution of this embodiment 4 is shown in Table 4:
[0092] Table 4 Prescription composition of iron protein succinate oral solution
[0093]
[0094]
[0095] Preparation method:
[0096] Take 80% of the prescribed amount of purified water after boiling and cooling, add the prescribed amount of glycerol, stir at 50°C, add the prescribed amount of protein succinate iron, the prescribed amount of fructose, the prescribed amount of xylitol, the prescribed amount of trehalose and the prescribed amount of glycine, stir at 50°C, adjust the pH to 7.6 with 4 mol / L sodium hydroxide aqueous solution, stir, add boiled and cooled purified water to make up to the dispensing volume, filter through a filter membrane to obtain the protein succinate iron oral solution.
[0097] Preparation stability study
[0098] 1. Investigation on the stability of influencing factors
[0099] 1.1 High temperature stability study
[0100] According to the guidelines for the stability test of preparations in the Chinese Pharmacopoeia, the stability of the oral iron protein succinate solution packaged in white plastic bottles prepared in Examples 1-4 was investigated at a high temperature of 60°C for 0 days, 5 days and 10 days, and the properties, free iron content (limit ≤ 0.1%) and iron protein succinate content (in terms of iron content, 95%-105% of the labeled amount) at different investigation points were observed and measured.
[0101] The high temperature stability test results of the oral iron protein succinate solution prepared in Examples 1-4 are shown in Table 5.
[0102] Table 5 Stability of the oral solution of iron protein succinate prepared in Example 1-4 at high temperature 60°C
[0103]
[0104] Note: “—” means no measurement is required.
[0105] As can be seen from Table 5, the iron protein succinate oral solution prepared in Example 1 has the best high temperature stability.
[0106] 1.2 Light stability study
[0107] According to the guidelines for the stability test of preparations in the Chinese Pharmacopoeia, the oral solution of iron protein succinate prepared in Examples 1-4 and packaged in white plastic bottles was examined for stability under illumination conditions (4500 lx, 25°C) for 0 days, 5 days and 10 days, and the properties, free iron content (limit ≤ 0.1%) and iron protein succinate content (in terms of iron content, 95%-105% of the labeled amount) at different inspection points were observed and measured.
[0108] The results of the light stability test of the oral solution of iron protein succinate prepared in Example 1-4 are shown in Table 6. Table 6 Stability test of the oral solution of iron protein succinate prepared in Example 1-4 under light conditions (4500 lx, 25°C)
[0109]
[0110] As can be seen from Table 6, the oral iron protein succinate solution prepared in Example 1 has the best light stability.
[0111] 2. Accelerated stability test
[0112] According to the guidance of the stability test of preparations in the Chinese Pharmacopoeia, the oral solution of iron protein succinate prepared in Example 1 and packaged in a white plastic bottle was inspected for stability at a temperature of 40±2°C and a relative humidity of RH 75±5% for 0 days, 1, 3 and 6 months, and the properties, free iron content (limit ≤0.1%) and iron protein succinate content (in terms of iron content, 95%-105% of the labeled amount) at different inspection points were observed and measured.
[0113] The results of the investigation of the oral iron protein succinate solution prepared in Example 1 at different investigation times at a temperature of 40±2° C. and a relative humidity of RH 75±5% are shown in Table 7.
[0114] Table 7 Accelerated stability test results of the oral solution of iron protein succinate prepared in Example 1 at a temperature of 40±2°C and a relative humidity of RH 75±5%
[0115]
[0116]
[0117] As can be seen from Table 7, the iron protein succinate oral solution prepared in Example 1 has excellent stability under accelerated conditions.
[0118] It can be seen from Tables 5, 6 and 7 that the oral solution of iron protein succinate prepared in Example 1 has the best stability, can reduce storage and transportation costs, ensure the stability of the oral solution of iron protein succinate during transportation and storage, and ensure quality safety and medication safety.
[0119] The above is an implementation scheme of the present invention designed for a case. It should be pointed out that for ordinary technicians in this technical field, several improvements can be made without departing from the principle of the present invention, and these improvements should also be regarded as the scope of protection of the present invention.
Claims
1. An oral solution of iron protein succinate, characterized in that: The ferric protein succinate oral solution comprises ferric protein succinate, glycerol, polyethylene glycol 400, fructose, xylitol, trehalose, glycine and water.
2. The iron protein succinate oral solution according to claim 1, wherein The iron protein succinate is 6-10 parts by weight, preferably 7-9 parts by weight, more preferably 7.5-8.5 parts by weight, most preferably 7.8-8.2 parts by weight, and most preferably 8.0 parts by weight; The glycerol is 1-3 parts by weight, preferably 1.5-2.5 parts by weight, more preferably 1.8-2.2 parts by weight, and most preferably 2.0 parts by weight; The polyethylene glycol 400 is 3-5 parts by weight, preferably 3.5-4.5 parts by weight, more preferably 3.8-4.2 parts by weight, and most preferably 4.0 parts by weight; The fructose is 5-7 parts by weight, preferably 5.5-6.5 parts by weight, more preferably 5.8-6.2 parts by weight, and most preferably 6.0 parts by weight; The xylitol is 0.5-2.0 parts by weight, preferably 0.8-1.5 parts by weight, more preferably 1.0-1.4 parts by weight, and most preferably 1.2 parts by weight. The trehalose is 1-4 parts by weight, preferably 2-3 parts by weight, more preferably 2.3-2.7 parts by weight, and most preferably 2.5 parts by weight; The glycine is 2-4 parts by weight, preferably 2.5-3.5 parts by weight, more preferably 2.8-3.2 parts by weight, and most preferably 3.0 parts by weight; The water is 130-170 parts by weight, preferably 140-160 parts by weight, more preferably 145-155 parts by weight, and most preferably 150 parts by weight.
3. The iron protein succinate oral solution according to claim 1, characterized in that The pH of the ferric protein succinate oral solution is adjusted with sodium hydroxide to 6.0-8.5, preferably 7.0-8.2, more preferably 7.2-8.0, more preferably 7.4-7.8, and most preferably 7.
6.
4. The iron protein succinate oral solution according to claim 1, characterized in that The iron protein succinate oral solution comprises: The pH of the ferric protein succinate oral solution was adjusted to 6.0-8.5 with sodium hydroxide.
5. The iron protein succinate oral solution according to claim 1, characterized in that The iron protein succinate oral solution comprises: The pH of the ferric protein succinate oral solution was adjusted to 7.2-8.0 with sodium hydroxide.
6. The iron protein succinate oral solution according to claim 1, characterized in that The iron protein succinate oral solution comprises: The pH of the ferric protein succinate oral solution was adjusted to 7.6 with sodium hydroxide.
7. The iron protein succinate oral solution according to claim 1, characterized in that The iron protein succinate oral solution comprises: The pH of the ferric protein succinate oral solution was adjusted to 7.6 with sodium hydroxide.
8. A method for preparing the iron protein succinate oral solution as claimed in claim 1, characterized in that: The method comprises the steps of: The iron protein succinate oral solution is obtained by mixing iron protein succinate, glycerol, polyethylene glycol 400, fructose, xylitol, trehalose, glycine and water.
9. Use of the iron protein succinate oral solution as claimed in claim 1, characterized in that: Used for preparing medicines for preventing and / or treating anemia.
10. The multi-purpose device according to claim 9, characterized in that: The anemia includes iron deficiency anemia.
